wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38221015-FE807909-0A0E-4982-B5FA-505277DD6694
Q38221015-FE807909-0A0E-4982-B5FA-505277DD6694
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38221015-FE807909-0A0E-4982-B5FA-505277DD6694
Proprotein convertase subtilisin/kexin 9 inhibitors: an emerging lipid-lowering therapy?
P2860
Q38221015-FE807909-0A0E-4982-B5FA-505277DD6694
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38221015-FE807909-0A0E-4982-B5FA-505277DD6694
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e536f3ae137b39663f61999f004138833c0441b5
P2860
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial.